Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP

NEXT STORY
Agios to Present Updated Clinical Proof-of-Concept Data from the Phase 2 Study of Mitapivat in Thalassemia in Oral Presentation at the European Hematology Association Annual Congress
PREV STORY
TG Therapeutics Announces Data Presentations at Upcoming Medical Meetings
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Codiak Announces Closing of $66.4 Million Public Offering, Including Full Exercise of Underwriters’ Option

author_avatar
NASDAQ Market News

Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Validating Microbiome Preservation, for its Investigational Drug Ridinilazole

author_avatar
NASDAQ Market News

Biomarkers Technologies, Markets and Companies Report 2018: Market Estimates for 2017-2027 with Profiles of 300+ Companies

Dublin, May 29, 2018 (GLOBE NEWSWIRE) -- The "Biomarkers - Technologies, Markets and Companies" ...

author_avatar
NASDAQ Market News